This week: R&D funding, pesticide ‘loopholes’, drug regulation and more
The EU’s innovation fund for technology development is again delaying its investments, and has apologised for “the difficult position” this puts grantees in. Since its 2021 launch, the European Innovation Council has delayed promised equity-based investments in dozens of companies. Now MEP Christian Ehler has shared a letter informing winners of a call with an October 2022 cut-off for applications that their grants will be delayed: “The approval process is ongoing, and contracts will be signed indicatively toward the end of April.” Ehler described the delay as “Kafkaesque”.
This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com
Pivot-RP users can log in and view the article via this link.